Clinical Trial Update: Repeat PET/CT Imaging in People With CAPS and Anakinra-Induced Amyloidosis Using an Amyloid-Reactive Peptide to Measure Changes in Organ-Specific Amyloid Load [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating repeat PET/CT imaging with an amyloid-reactive peptide to measure changes in organ-specific amyloid load in people with Cryopyrin-Assoc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aa Amyloidosis
• Cryopyrin-associated Periodic Syndromes

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Cryopyrin-Associated Periodic Syndromes, Amyloidosis | Phase 1 | Status: RECRUITING